PBM regulation push hits union snag

New York lawmakers are prioritizing a bill to more tightly regulate drug-price middlemen, with three weeks to go in the legislative session.

But they’ve hit a last-minute hitch: pushback from powerful unions.

Groups representing New York City teachers and municipal workers oppose the bill, complicating its chances for passage in the waning weeks of the lawmaking session, my colleague Zach Williams reports.

“We cannot support legislation that could increase drug prices for our members,” said Michael Mulgrew, president of the 190,000-member United Federation of Teachers.

The legislation would would require pharmacy benefit managers—who negotiate prescription drug prices among pharma companies, ...